Investigator site 0010003 — Chapel Hill, North Carolina

Investigator site 0010003 is a clinical research site located in Chapel Hill, North Carolina, United States 27517.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator site 0010003 has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Sponsors: argenx.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator site 0010003?

Investigator site 0010003 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator site 0010003 conducted?

Investigator site 0010003 has 2 clinical trials on record, with 1 currently active. Their work covers Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Is Investigator site 0010003 accredited by Crixeo Clinical Trials?

Investigator site 0010003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator site 0010003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.